Trulieve reschedules earnings call a week to March 8
Zerbor
- Trulieve Cannabis (OTCQX:TCNNF) is delaying its Q4 and full-year 2022 financial results release to March 8. It was previously scheduled for March 1.
- The reason for the delay is that as of Dec. 31, 2022, Trulieve (OTCQX:TCNNF) no longer qualified as an emerging growth company. As a result, it has a 60-day 10-K filing deadline as opposed to 90 days.
- "The Company and its auditors need additional time to complete its audit of financial statements and internal control over financial reporting," Trulieve (OTCQX:TCNNF) said in a news release.
- Read why Seeking Alpha contributor Cannabis Growth Investor reiterated its strong buy recommendation for Trulieve (OTCQX:TCNNF).